These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 35047549)

  • 1. Understanding the Effects of Antipsychotics on Appetite Control.
    Mukherjee S; Skrede S; Milbank E; Andriantsitohaina R; López M; Fernø J
    Front Nutr; 2021; 8():815456. PubMed ID: 35047549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.
    Miyamoto S; Miyake N; Jarskog LF; Fleischhacker WW; Lieberman JA
    Mol Psychiatry; 2012 Dec; 17(12):1206-27. PubMed ID: 22584864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting Typical and Atypical Antipsychotic Drugs.
    Meltzer HY; Gadaleta E
    Focus (Am Psychiatr Publ); 2021 Jan; 19(1):3-13. PubMed ID: 34483761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antipsychotic medications on appetite, weight, and insulin resistance.
    Deng C
    Endocrinol Metab Clin North Am; 2013 Sep; 42(3):545-63. PubMed ID: 24011886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin receptors: their key role in drugs to treat schizophrenia.
    Meltzer HY; Li Z; Kaneda Y; Ichikawa J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonergic mechanisms as targets for existing and novel antipsychotics.
    Meltzer HY
    Handb Exp Pharmacol; 2012; (212):87-124. PubMed ID: 23129329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on typical and atypical antipsychotic drugs.
    Meltzer HY
    Annu Rev Med; 2013; 64():393-406. PubMed ID: 23020880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of serotonin receptors in the action of atypical antipsychotic drugs.
    Meltzer HY; Massey BW
    Curr Opin Pharmacol; 2011 Feb; 11(1):59-67. PubMed ID: 21420906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of typical and atypical antipsychotic drugs on striosome and matrix compartments of the striatum.
    Bubser M; Deutch AY
    Eur J Neurosci; 2002 Feb; 15(4):713-20. PubMed ID: 11886451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of second-generation antipsychotics on the use of antiparkinson agents in nursing homes and assisted-living facilities.
    Touré JT; Brandt NJ; Limcangco MR; Briesacher BA
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):25-35. PubMed ID: 16730618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Mechanisms of Antipsychotic Drug-Induced Diabetes.
    Chen J; Huang XF; Shao R; Chen C; Deng C
    Front Neurosci; 2017; 11():643. PubMed ID: 29209160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug induced weight gain, an impediment to successful pharmacotherapy: focus on antipsychotics.
    Baptista T; Zárate J; Joober R; Colasante C; Beaulieu S; Páez X; Hernández L
    Curr Drug Targets; 2004 Apr; 5(3):279-99. PubMed ID: 15058313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Schizophrenia, diabetes mellitus and antipsychotics].
    Gury C
    Encephale; 2004; 30(4):382-91. PubMed ID: 15538314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes.
    Silvestre JS; Prous J
    Methods Find Exp Clin Pharmacol; 2005 Jun; 27(5):289-304. PubMed ID: 16082416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents.
    Black MD; Stevens RJ; Rogacki N; Featherstone RE; Senyah Y; Giardino O; Borowsky B; Stemmelin J; Cohen C; Pichat P; Arad M; Barak S; De Levie A; Weiner I; Griebel G; Varty GB
    Psychopharmacology (Berl); 2011 May; 215(1):149-63. PubMed ID: 21181124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional differences in the action of antipsychotic drugs: implications for cognitive effects in schizophrenic patients.
    Beninger RJ; Baker TW; Florczynski MM; Banasikowski TJ
    Neurotox Res; 2010 Nov; 18(3-4):229-43. PubMed ID: 20376711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents.
    Toren P; Ratner S; Laor N; Weizman A
    Drug Saf; 2004; 27(14):1135-56. PubMed ID: 15554747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molindone for schizophrenia and severe mental illness.
    Bagnall A; Fenton M; Lewis R; Leitner ML; Kleijnen J
    Cochrane Database Syst Rev; 2000; (2):CD002083. PubMed ID: 10796464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia.
    Tandon R; Belmaker RH; Gattaz WF; Lopez-Ibor JJ; Okasha A; Singh B; Stein DJ; Olie JP; Fleischhacker WW; Moeller HJ;
    Schizophr Res; 2008 Mar; 100(1-3):20-38. PubMed ID: 18243663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.